Document is current

Any future updates will be listed below

Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05153-4

Published Online: 2021-03-05

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark